PMC:7405836 / 117271-117574 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T46","span":{"begin":17,"end":23},"obj":"Body_part"},{"id":"T47","span":{"begin":64,"end":69},"obj":"Body_part"},{"id":"T48","span":{"begin":71,"end":79},"obj":"Body_part"},{"id":"T49","span":{"begin":123,"end":131},"obj":"Body_part"},{"id":"T50","span":{"begin":218,"end":224},"obj":"Body_part"}],"attributes":[{"id":"A46","pred":"fma_id","subj":"T46","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A49","pred":"fma_id","subj":"T49","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A50","pred":"fma_id","subj":"T50","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T130","span":{"begin":64,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A130","pred":"uberon_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1037","span":{"begin":37,"end":45},"obj":"Disease"},{"id":"T1038","span":{"begin":37,"end":41},"obj":"Disease"}],"attributes":[{"id":"A1037","pred":"mondo_id","subj":"T1037","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A1038","pred":"mondo_id","subj":"T1038","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T135","span":{"begin":17,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T136","span":{"begin":35,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T137","span":{"begin":218,"end":224},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T138","span":{"begin":246,"end":247},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T792","span":{"begin":0,"end":303},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3196","span":{"begin":37,"end":47},"obj":"Species"},{"id":"3197","span":{"begin":196,"end":204},"obj":"Species"}],"attributes":[{"id":"A3196","pred":"tao:has_database_id","subj":"3196","obj":"Tax:2697049"},{"id":"A3197","pred":"tao:has_database_id","subj":"3197","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The convalescent plasma containing a SARS-CoV-2-specific ELISA (serum) antibody titer higher than 1:1,000 and neutralizing antibody titer more significant than 40 was collected from the recovered patients and used for plasma transfusion twice in a volume of 200 to 250 ml on the day of collection (310)."}